Getein Biotech, Inc. (603387) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Getein Biotech, Inc.

Why is Getein Biotech, Inc. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.11% and Operating profit at -13.29% over the last 5 years

The company has declared Negative results for the last 10 consecutive quarters

NET PROFIT(9M) At CNY 143.02 MM has Grown at -25.74%
ROCE(HY) Lowest at 7.58%
INTEREST(Q) At CNY 3.69 MM has Grown at 30.72%

With ROE of 6.40%, it has a very attractive valuation with a 1.52 Price to Book Value

Over the past year, while the stock has generated a return of -6.95%, its profits have fallen by -32.8%
At the current price, the company has a high dividend yield of 2.2

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -6.95% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Getein Biotech, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Getein Biotech, Inc. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Getein Biotech, Inc.

-6.95%

-0.05

24.58%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.11%

EBIT Growth (5y)

-13.29%

EBIT to Interest (avg)

25.02

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.10

Sales to Capital Employed (avg)

0.40

Tax Ratio

7.24%

Dividend Payout Ratio

40.82%

Pledged Shares

Institutional Holding

ROCE (avg)

22.03%

ROE (avg)

14.75%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.52

EV to EBIT

22.17

EV to EBITDA

13.33

EV to Capital Employed

1.82

EV to Sales

2.96

PEG Ratio

Dividend Yield

2.24%

ROCE (Latest)

8.19%

ROE (Latest)

6.40%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -18.1% (YoY

-24What is not working for the Company

NET PROFIT(9M)

At CNY 143.02 MM has Grown at -25.74%

ROCE(HY)

Lowest at 7.58%

INTEREST(Q)

At CNY 3.69 MM has Grown at 30.72%

CASH AND EQV(HY)

Lowest at CNY 1,871.43 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.74%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.42%

NET SALES(Q)

Lowest at CNY 241.38 MM

Here's what is working for Getein Biotech, Inc.

Raw Material Cost

Fallen by -18.1% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Getein Biotech, Inc.

Net Sales

At CNY 241.38 MM has Fallen at -16.07%

over average net sales of the previous four periods of CNY 287.6 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Interest

At CNY 3.69 MM has Grown at 30.72%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 143.02 MM has Grown at -25.74%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 241.38 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Cash and Eqv

Lowest at CNY 1,871.43 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 1.74%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.42%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio